Linking up and interacting with BRCT domains

DNA Repair

Volumn 9, Issue 2, 2010, Pages 103-108

  Watts, Felicity Z ^a   Brissett, Nigel C ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

53BP1; BRCA1; Crb2; DNA ligase IV

Indexed keywords

BRCA1 PROTEIN; DNA LIGASE IV; PHOSPHOPROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN 53BP1; PROTEIN BRCT; PROTEIN P53; PROTEIN RAD9; SCHIZOSACCHAROMYCES POMBE PROTEIN; SCHIZOSACCHAROMYCES POMBE PROTEIN CRB2; UNCLASSIFIED DRUG; XRCC4 PROTEIN;

AMINO TERMINAL SEQUENCE; ARCHITECTURE; BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CRYSTAL STRUCTURE; DNA CROSS LINKING; DNA REPAIR; GENE MUTATION; HUMAN; MOLECULAR MODEL; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SCHIZOSACCHAROMYCES POMBE; X RAY CRYSTALLOGRAPHY;

CELL CYCLE PROTEINS; DISEASE; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY;

SCHIZOSACCHAROMYCES POMBE;

EID: 75449115140     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2009.10.010     Document Type: Review

References (34)

1. Bork P., Hofmann K., Bucher P., Neuwald A.F., Altschul S.F., and Koonin E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 11 (1997) 68-76
2. Callebaut I., and Mornon J.P. From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS Lett. 400 (1997) 25-30
3. Huyton T., Bates P.A., Zhang X., Sternberg M.J., and Freemont P.S. The BRCA1 C-terminal domain: structure and function. Mutat. Res. 460 (2000) 319-332
4. Manke I.A., Lowery D.M., Nguyen A., and Yaffe M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302 (2003) 636-639
5. Varma A.K., Brown R.S., Birrane G., and Ladias J.A. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex. Biochemistry 44 (2005) 10941-10946
6. Lee M.S., Edwards R.A., Thede G.L., and Glover J.N. Structure of the BRCT repeat domain of MDC1 and its specificity for the free COOH-terminal end of the gamma-H2AX histone tail. J. Biol. Chem. 280 (2005) 32053-32056
7. Shiozaki E.N., Gu L., Yan N., and Shi Y. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling. Mol. Cell 14 (2004) 405-412
8. Stucki M., Clapperton J.A., Mohammad D., Yaffe M.B., Smerdon S.J., and Jackson S.P. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123 (2005) 1213-1226
9. Kilkenny M.L., Dore A.S., Roe S.M., Nestoras K., Ho J.C., Watts F.Z., and Pearl L.H. Structural and functional analysis of the Crb2-BRCT2 domain reveals distinct roles in checkpoint signaling and DNA damage repair. Genes Dev. 22 (2008) 2034-2047
10. Zhang X., Morera S., Bates P.A., Whitehead P.C., Coffer A.I., Hainbucher K., Nash R.A., Sternberg M.J., Lindahl T., and Freemont P.S. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module. EMBO J. 17 (1998) 6404-6411
11. Dulic A., Bates P.A., Zhang X., Martin S.R., Freemont P.S., Lindahl T., and Barnes D.E. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III. Biochemistry 40 (2001) 5906-5913
12. Lee J.Y., Chang C., Song H.K., Moon J., Yang J.K., Kim H.K., Kwon S.T., and Suh S.W. Crystal structure of NAD(+)-dependent DNA ligase: modular architecture and functional implications. EMBO J. 19 (2000) 1119-1129
13. Williams R.S., Green R., and Glover J.N. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol. 8 (2001) 838-842
14. Derbyshire D.J., Basu B.P., Serpell L.C., Joo W.S., Date T., Iwabuchi K., and Doherty A.J. Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J. 21 (2002) 3863-3872
15. Joo W.S., Jeffrey P.D., Cantor S.B., Finnin M.S., Livingston D.M., and Pavletich N.P. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 16 (2002) 583-593
16. Critchlow S.E., Bowater R.P., and Jackson S.P. Mammalian DNA double-strand break repair protein XRCC4 interacts with DNA ligase IV. Curr. Biol. 7 (1997) 588-598
17. Grawunder U., Zimmer D., and Leiber M.R. DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains. Curr. Biol. 8 (1998) 873-876
18. Grawunder U., Wilm M., Wu X., Kulesza P., Wilson T.E., Mann M., and Lieber M.R. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 388 (1997) 492-495
19. Wu P.Y., Frit P., Meesala S., Dauvillier S., Modesti M., Andres S.N., Huang Y., Sekiguchi J., Calsou P., Salles B., and Junop M.S. Structural and functional interaction between the human DNA repair proteins DNA ligase IV and XRCC4. Mol. Cell. Biol. 29 (2009) 3163-3172
20. Sibanda B.L., Critchlow S.E., Begun J., Pei X.Y., Jackson S.P., Blundell T.L., and Pellegrini L. Crystal structure of an Xrcc4-DNA ligase IV complex. Nat. Struct. Biol. 8 (2001) 1015-1019
21. Dore A.S., Furnham N., Davies O.R., Sibanda B.L., Chirgadze D.Y., Jackson S.P., Pellegrini L., and Blundell T.L. Structure of an Xrcc4-DNA ligase IV yeast ortholog complex reveals a novel BRCT interaction mode. DNA Repair (Amst.) 5 (2006) 362-368
22. Girard P.M., Kysela B., Harer C.J., Doherty A.J., and Jeggo P.A. Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphisms. Hum. Mol. Genet. 13 (2004) 2369-2376
23. Soulier J., and Lowndes N.F. The BRCT domain of the S. cerevisiae checkpoint protein Rad9 mediates a Rad9-Rad9 interaction after DNA damage. Curr. Biol. 9 (1999) 551-554
24. Du L.L., Moser B.A., and Russell P. Homo-oligomerization is the essential function of the tandem BRCT domains in the checkpoint protein Crb2. J. Biol. Chem. 279 (2004) 38409-38414
25. Weinert T.A., and Hartwell L.H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241 (1988) 317-322
26. Willson J., Wilson S., Warr N., and Watts F.Z. Isolation and characterization of the Schizosaccharomyces pombe rhp9 gene: a gene required for the DNA damage checkpoint but not the replication checkpoint. Nucleic Acids Res. 25 (1997) 2138-2146
27. Usui T., Foster S.S., and Petrini J.H. Maintenance of the DNA-damage checkpoint requires DNA-damage-induced mediator protein oligomerization. Mol. Cell 33 (2009) 147-159
28. Cho Y., Gorina S., Jeffrey P.D., and Pavletich N.P. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265 (1994) 346-355
29. Gayther S.A., Warren W., Mazoyer S., Russell P.A., Harrington P.A., Chiano M., Seal S., Hamoudi R., van Rensburg E.J., Dunning A.M., Love R., Evans G., Easton D., Clayton D., Stratton M.R., and Ponder B.A. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat. Genet. 11 (1995) 428-433
30. Couch F.J., DeShano M.L., Blackwood M.A., Calzone K., Stopfer J., Campeau L., Ganguly A., Rebbeck T., and Weber B.L. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N. Engl. J. Med. 336 (1997) 1409-1415
31. Scully R., and Livingston D.M. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408 (2000) 429-432
32. Welcsh P.L., Owens K.N., and King M.C. Insights into the functions of BRCA1 and BRCA2. Trends Genet. 16 (2000) 69-74
33. Konstantopoulou I., Rampias T., Ladopoulou A., Koutsodontis G., Armaou S., Anagnostopoulos T., Nikolopoulos G., Kamakari S., Nounesis G., Stylianakis A., Karanikiotis C., Razis E., Gogas H., Keramopoulos A., Gaki V., Markopoulos C., Skarlos D., Pandis N., Bei T., Arzimanoglou I., Fountzilas G., and Yannoukakos D. Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients. Breast Cancer Res. Treat. 107 (2008) 431-441
34. Valarmathi M.T., Agarwal A., Deo S.S., Shukla N.K., and Das S.N. BRCA1 germline mutations in Indian familial breast cancer. Hum. Mutat. 21 (2003) 98-99